InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,724.80
(
0.01%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.13
(
-0.10%
)
Bitcoin
61,657.83
(
-1.98%
)
Post# of 9487
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

inspro

Send PM Follow Ignore
Followers 5
Posts 901
Boards Moderated 0
Alias Born 07/25/2005

inspro

Re: None

Tuesday, 01/19/2010 9:26:59 AM

Tuesday, January 19, 2010 9:26:59 AM

Post# of 9487
GenVec will collaborate with Novartis AG (NVS) in developing treatments for hearing loss and balance disorders, saying it could receive as much as $213.6 million in upfront and milestone payments from the partnership. GenVec's shares jumped 20% to $2.08
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up